This article was originally published in The Rose Sheet
First quarter sales jumped 80% to $1.8 mil. due to higher skin care sales and licensing royalties, Kinetin manufacturer says. Company records a net loss of $593,000 compared to deficit of $1.4 mil. in prior-year period. Effort to focus on high-margin royalty income received from licenses led to improved results, Napa, Calif. firm maintains. Senetek licenses its Kinetin technology to Revlon and The Body Shop among other firms
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
The National Advertising Division concludes that by claiming the Schick Intuition Plus razor "lathers, shaves and moisturizes in one easy step," Energizer Personal Care is implying a long-term post-shave benefit comparable to that awarded by leave-on moisturizer, which is not supported by the company's evidence